Hydrogel spacers for patients with prostate cancer a review of clinical effectiveness and cost-effectiveness
The use of hydrogel spacers has demonstrated some clinical effectiveness in the prevention of rectal toxicity to treat patients with localized prostate cancer undergoing radiotherapy, but it is uncertain whether the benefits of hydrogel spacers outweigh the costs and potential harms and whether spac...
| Main Authors: | , , |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
CADTH
February 22, 2019, 2019
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The use of hydrogel spacers has demonstrated some clinical effectiveness in the prevention of rectal toxicity to treat patients with localized prostate cancer undergoing radiotherapy, but it is uncertain whether the benefits of hydrogel spacers outweigh the costs and potential harms and whether spacers should be used routinely. This review aims to summarize the available literature to inform an improved understanding of the benefits, harms and costs of hydrogel spacer use |
|---|---|
| Physical Description: | 1 PDF file (36 pages) illustrations |